CRDL: Cardiol Therapeutics Company Current Liabilities

Graphic logo of Cardiol (CRDL)

Cardiol Therapeutics (CRDL) is developing clean anti-inflammatory drugs for myocarditis without side effects, utilizing digital oversight of external clinical trials. The model scales via contract manufacturing, ensuring high profitability against fixed development costs. The short-term debt history on the GURU.Markets portal demonstrates the current load, where 0.00 shows the current volume of short-term liabilities.

CRDL (Cardiol) Company Current Liabilities history from 07/04/2022 to 10/31/2026

Analytical breakdowns for Cardiol Therapeutics Inc (CRDL)

- current quotes and average value forecast:
Price Chart Cardiol|CRDL - Fair Value Consensus
- market capitalization information:
Market Valuation Cardiol Therapeutics Inc.|CRDL - Aggregate Business Value
- balance sheet net asset value indicators:
Book Value per Share Cardiol Therapeutics|CRDL - Company Net Assets|Market Capitalization to Book Value Ratio cardiolrx.com|CRDL - Company Total Assets
- business debt structure and liquidity details:
Debt to Equity Cardiol Therapeutics|CRDL - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Cardiol|CRDL - Company Aggregate Debt|Debts to Book Capitalization Cardiol Therapeutics Inc.|CRDL - Long-Term Debt Volume|Company Short-Term Debt Cardiol Therapeutics|Quick Liquidity cardiolrx.com
- net income and valuation multiples indicators:
CRDL - Company Net Income
Fundamental valuation:cardiolrx.com (CRDL)
Mass-produced product of Cardiol Therapeutics Inc

The high macro-resilience of Cardiol Therapeutics (CRDL) is driven by the non-cyclical nature of cardiology drug development, where success depends on clinical trials rather than market conditions. An analysis of current short-term liabilities allows for an assessment of cash flow gap risks via the amount of debt maturing within one year, which is critical for ensuring the company's liquidity during periods of intensive research.

Competitors of Cardiol Therapeutics

REGN - Company Short-Term Debt|Company Short-Term Loans and Borrowings IRTC (iRhythm Technologies, Inc.)|LNTH (Lantheus Medical Imaging) - Company Current Liabilities|MLYS: Amount of Current Liabilities|HTFL (HeartFlow Inc) - Company Short-Term Debts|Company Current Liabilities kestramedical.com (KMTS)|Company Short-Term Debts ESPR|Company Short-Term Debts Amarin Corporation (AMRN)|Company Short-Term Debt Anteris Technologies AVR|Company Short-Term Loans and Borrowings TNYA|CVRx, Inc. - Company Short-Term Debts|MIST (milestonepharma.com) - Company Short-Term Indebtedness|BEAT: Company Short-Term Debts|TENX - Short-Term Debt Volume|Company Short-Term Debt Adagio Medical Holdings Inc.|Short-Term Debt BioCardia Inc BCDA|Company Short-Term Debt Catheter Precision (VTAK)|Company Short-Term Debt ABIO (arcabio.com)|Acasti Pharma Inc. - Company Current Liabilities|Company Short-Term Loans and Borrowings AVTE|VERV: Company Current Liabilities|Windtree Therapeutics - Amount of Current Liabilities